Prof. Taylor is Director of Regenerative Medicine Research at the Texas Heart Institute. She is also faculty member of Integrative Biology and Physiology at the University of Minnesota, and of the Graduate Faculty at Texas A&M University. Dr. Taylor is a globally recognized scientist credited with a number of important scientific breakthroughs related to cell therapy, stem cell biology, and tissue-engineering-based therapies. She holds a number of invention disclosures and patent applications and patents. As a pioneer in cardiovascular cell therapy, Dr. Taylor’s mechanistic insights and effective approaches to cardiac repair and replacement are well established and include a number of firsts.
She currently serves on California National Primate Research Center, UC Davis as an External Advisory Board member and Keystone Symposia Scientific Advisory Board. She is a dedicated educator with over 25 years of teaching experience and mentoring. Dr. Taylor has served as an advisor to multiple committees, including the FDA Cellular, Tissue and Gene Therapies Advisory Committee, Department of Health and Human Services from 2005-2010 and is currently serving as a consulting member to the FDA Research Review Sub-Committee, Cellular, Tissue and Gene Therapies Advisory Board, Bethesda, Maryland. Dr. Doris Taylor has an extensive scientific publication record and has authored or co-authored more than 80 scientific publications.
A well known researcher and lecturer internationally, Dr. Taylor holds many honors including: Fellow, American Heart Association and the Council on Functional Genomics and Translational Biology, Fellow, American College of Cardiology, Fellow, American Heart Association and the Council on Basic Cardiovascular Sciences, and American Heart Association Top 10 Research Advances.
2013-2017©European Society for Translational Medicine (EUSTM)